期刊文献+

CD40L刺激诱导型环氧合酶表达及普伐他汀的作用 被引量:1

Effect of pravastatin on cyclooxygenase-2 expression induced by rhCD40L in cultured U937 cells
下载PDF
导出
摘要 目的探讨重组人CD40配体(rhCD40L)对培养的人单核细胞(U937)表达诱导型环氧合酶(COX-2)的作用和普伐他汀对其影响。方法体外培养U937细胞,以0.05、0.1、0.2μg/m l的rhCD40L分别刺激24 h;0.4μg/m l的rhCD40L分别刺激3、6、12、24 h;终浓度10、1、0.1 mmol/L的普伐他汀与0.4μg/m l的rhCD40L共同刺激U937细胞24 h。RT-PCR检测COX-2 mRNA表达,W estern-b lot检测COX-2蛋白表达,ELISA法检测前列腺素E2(PGE2)的浓度反映COX-2酶活性。结果0.4μg/m l的rhCD40L刺激后3 h可诱导COX-2 mRNA和蛋白表达,随着rh-CD40L浓度和作用时间增加,COX-2 mRNA和蛋白表达显著增加(P<0.01),且呈时效和量效关系;同样,rhCD40L以时间和剂量依赖的方式增加U937细胞中PGE2的合成。0.4μg/m l的rhCD40L与普伐他汀共同刺激24 h后,COX-2的表达显著被抑制。结论rhCD40L以时间和浓度依赖的方式诱导COX-2的表达,普伐他汀可以抑制此作用。 AIM To evaluate cyclooxygenase-2 expression induced by rhCD40L in cultured U937 cells and possible inhabition inhibition by pravastatin. METHODS U937 cells were pretreated with rhCD40L of different concentrations and time intervals and COX-2 mRNA and protein expression were observed by RT-PCR and Western-blot respectively. For COX-2 enzyme activity, PGE2 released by U937 cells was measured by ELISA. RESULTS rhCD40L increased the expression of COX-2 in a time- and dose-dependent manner ( P 〈 0.01 ). Pravastatin inhibited the expression of COX-2 induced by rhCD40L in a dose-dependent manner (P 〈0.01 ). CONCLUSION rhCD40L can induce cyclooxygenase-2 expression in a dose and time dependent manner. Pravastatin inhibits this enhanced expression in U937 cells.
出处 《心脏杂志》 CAS 2006年第3期245-248,共4页 Chinese Heart Journal
关键词 CD40L配体 诱导型环氧合酶 普伐他汀 单核细胞 CD40 ligand cyclooxygenase-2 pravastatin monocyte
  • 相关文献

参考文献14

  • 1Rose R. Atherosclerosis - an inflammatory disease [J]. N Engl J Med, 1999, 340(2) :115 - 126.
  • 2Linton MF, Fazio S. Cyclooxygenase-2 and atherosclerosis[J]. Curr Opin Lipidol, 2002,13(5): 497 -504.
  • 3Mitchell JA, Warner TD. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy [J]. Br J Pharmacol, 1999, 128(6): 1121-1132.
  • 4Massy ZA, Swan SK. Cyclooxygenase-2 and atherosclerosis: friendor foe? [J]. Nephrol Dial Transplant, 2001, 16(12): 2286 -2289.
  • 5Aukrust P, Muller F, Ueland T, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina.Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes [J]. Circulation, 1999, 100(6):614 -620.
  • 6Lutgens E, Daemen MJ. CD40-CD40L interactions in atherosclerosis [J]. Trends Cardiovasc Med, 2002,12(1):27 -32.
  • 7Lutgens E, Gorelik L, Daemen MJ, et al. Requirement for CD154 in the progression of atherosclerosis [J]. Nat Med , 1999,5(11): 1313 -1316.
  • 8Schonbeck U, Libby P. CD40 signaling and plaque instability [J].Circ Res, 2001,89(12):1092-1103.
  • 9Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor [J]. Circulation, 1997,96(2): 396-399.
  • 10Zhang Y, Cao HJ, Graf B, et al. CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts[J]. J Immunol, 1998,160(3): 1053-1057.

同被引文献8

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部